PreciThera, Inc. is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients
Looking for a particular PreciThera, Inc. employee's phone or email?
The PreciThera, Inc. annual revenue was $1 million in 2026.
Susan Schiavi is the Chief Scientific Officer of PreciThera, Inc..
1 people are employed at PreciThera, Inc..
PreciThera, Inc. is based in Montreal, Quebec.
The NAICS codes for PreciThera, Inc. are [54171, 541713, 541, 54, 5417].
The SIC codes for PreciThera, Inc. are [873, 87].